VRXA CIK: 2079109

Veraxa Biotech AG - Post de-SPAC

  • Germany
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY25
millions CHF
FY23:
−7.27
FY24:
−7.72
FY25:
−9.90
Change from FY23 to FY24
millions CHF
FY23:
−0.78
FY24:
0
FY25:
–
Change from FY23 to FY25
millions CHF
FY23:
12.5
FY24:
1.85
FY25:
6.59
(positive)
Change from FY23 to FY25
millions CHF
FY23:
−7.50
FY24:
−7.84
FY25:
−10.3

All amounts in millions CHF Data source:Twelve Data